Discovery of Potent, Selective Chymase Inhibitors via Fragment Linking Strategies

被引:27
|
作者
Taylor, Steven J. [1 ]
Padyana, Anil K. [1 ]
Abeywardane, Asitha [1 ]
Liang, Shuang [1 ]
Hao, Ming-Hong [6 ]
De Lombaert, Stephane [7 ]
Proudfoot, John [1 ]
Farmer, Bennett S., III [3 ]
Li, Xiang [1 ]
Collins, Brandon [1 ]
Martin, Leslie [4 ]
Albaugh, Daniel R. [1 ]
Hill-Drzewi, Melissa [5 ]
Pullen, Steven S. [2 ]
Takahashi, Hidenori [1 ]
机构
[1] Boehringer Ingelheim Pharmaceut Inc, Dept Med Chem, Ridgefield, CT 06877 USA
[2] Boehringer Ingelheim Pharmaceut Inc, Cardiometab Dis, Ridgefield, CT 06877 USA
[3] Boehringer Ingelheim Pharmaceut Inc, IS Sci Informat Management, Ridgefield, CT 06877 USA
[4] Boehringer Ingelheim Pharmaceut Inc, IS Res Data Acquisit, Ridgefield, CT 06877 USA
[5] Bristol Myers Squibb Co, Lead Evaluat Dept, Wallingford, CT 06492 USA
[6] H3 Biomed, Cambridge, MA 02139 USA
[7] Karos Pharmaceut, New Haven, CT 06511 USA
关键词
MAST-CELLS; PATHOPHYSIOLOGICAL ROLE; MECHANISMS; INFARCTION; FIBROSIS; TARGET;
D O I
10.1021/jm400138z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chymase plays an important and diverse role in the homeostasis of a number of cardiovascular processes. Herein, we describe the identification of potent, selective chymase inhibitors, developed using fragment-based, structure-guided linking and optimization techniques. High-concentration biophysical screening methods followed by high-throughput crystallography identified an oxindole fragment bound to the S1 pocket of the protein exhibiting a novel interaction pattern hitherto not observed in chymase inhibitors. X-ray crystallographic structures were used to guide the elaboration/linking of the fragment, ultimately leading to a potent inhibitor that was >100-fold selective over cathepsin G and that mitigated a number of liabilities associated with poor physicochemical properties of the series it was derived from.
引用
收藏
页码:4465 / 4481
页数:17
相关论文
共 50 条
  • [31] Discovery of Potent, Selective and Reversible Caspase-3 Inhibitors
    André Giroux
    John Colucci
    Christopher I. Bayly
    Daniel J. Mckay
    Sophie Roy
    Steve Xanthoudakis
    John Vaillancourt
    Dita M. Rasper
    John Tam
    Paul Tawa
    Donald W. Nicholson
    Robert J. Zamboni
    合成化学, 2004, (S1) : 13 - 13
  • [32] Discovery of potent and selective inhibitors of cyclin-dependent kinases
    Keertikar, Kerry M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [33] Discovery and optimization of potent, selective, and in vivo efficacious BCATm inhibitors
    Deng, Hongfeng
    Zhou, Jingye
    Sundersingh, Flora
    Messer, Jeff
    Somers, Don
    Beljean, Arthur
    Belyanskaya, Svetlana
    Bingham, Ryan
    Blazensky, Emily
    Boursier, Eric
    Chai, Jing
    Carter, Paul
    Chung, Chun-wa
    Daugan, Alain
    Ding, Yun
    Humphries, Eric
    Kollmann, Chris
    Smith, Sarah
    Dodic, Nerina
    Ancellin, Nicolas
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [34] Discovery of potent, selective inhibitors of mutant B-Raf
    Palmer, Cynthia L.
    Cui, Jingrong
    Deal, Judith
    Gu, Danlin
    Guo, Chuangxing
    Kephart, Susan
    Linton, Maria A.
    McAlpine, Indrawan
    Pairish, Mason
    Bagrodia, Shubha
    Cao, Yixue
    Yamazaki, Shinji
    DeLisle, Dorothy
    John-Baptiste, Annette
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [35] Discovery of potent, selective dipeptidyl peptidase IV inhibitors.
    Parmee, ER
    He, JF
    Mastracchio, A
    Edmondson, SD
    Xu, JY
    Colwell, LE
    Fisher, ME
    Habulihaz, B
    He, HB
    Leiting, B
    Lyons, K
    Marsilio, F
    Patel, R
    Wu, JK
    Wyvratt, MJ
    Thornberry, N
    Weber, AE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U177 - U177
  • [36] Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors
    Peterson, Emily A.
    Boezio, Alessandro A.
    Andrews, Paul S.
    Boezio, Christiane M.
    Bush, Tammy L.
    Cheng, Alan C.
    Choquette, Deborah
    Coats, James R.
    Colletti, Adria E.
    Copeland, Katrina W.
    DuPont, Michelle
    Graceffa, Russell
    Grubinska, Barbara
    Kim, Joseph L.
    Lewis, Richard T.
    Liu, Jingzhou
    Mullady, Erin L.
    Potashman, Michele H.
    Romero, Karina
    Shaffer, Paul L.
    Stanton, Mary K.
    Stellwagen, John C.
    Teffera, Yohannes
    Yi, Shuyan
    Cai, Ti
    La, Daniel S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 4967 - 4974
  • [37] Discovery of imidazopyridazinecarbonitriles as potent, selective inhibitors of CK2.
    Fink, Brian
    Gavai, Ashvinikumar
    Kim, Soong-Hoon
    Zhao, Yufen
    Purandare, Ashok
    Vite, Gregory
    Tokarski, John
    Yu, Chiang
    Henley, Benjamin
    Fargnoli, Joseph
    Desilva, Heshani
    Ross-MacDonald, Petra
    Rupnow, Brent
    Wong, Tai W.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [38] Discovery of Potent and Selective Inhibitors of Trypanosoma brucei Ornithine Decarboxylase
    Smithson, David C.
    Lee, Jeongmi
    Shelat, Anang A.
    Phillips, Margaret A.
    Guy, R. Kiplin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (22) : 16771 - 16781
  • [39] Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors
    Hanan, Emily J.
    van Abbema, Anne
    Barrett, Kathy
    Blair, Wade S.
    Blaney, Jeff
    Chang, Christine
    Eigenbrot, Charles
    Flynn, Sean
    Gibbons, Paul
    Hurley, Christopher A.
    Kenny, Jane R.
    Kulagowski, Janusz
    Lee, Leslie
    Magnuson, Steven R.
    Morris, Claire
    Murray, Jeremy
    Pastor, Richard M.
    Rawson, Tom
    Siu, Michael
    Ultsch, Mark
    Zhou, Aihe
    Sampath, Deepak
    Lyssikatos, Joseph P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 10090 - 10107
  • [40] Discovery of potent and selective inhibitors of neuronal nitric oxide synthase
    Ji, Haitao
    Jing, Qing
    Xue, Fengtian
    Li, Huiying
    Martasek, Pavel
    Roman, Linda J.
    Poulos, Thomas L.
    Silverman, Richard B.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241